The purpose of the Neuropathology Core and the Bryan Autopsy Program are to support the functions of the Clinical, Data Management, and Education Cores as well as our newly formed """"""""Genomics Core,"""""""" a privately supported collaborative initiative of the Bryan ADRC with the Institute of Genome Sciences and Policy (IGSP) to advance our Center's Genomic Medicine objectives. The Core provides diagnostic and tissue banking functions to support the Bryan ADRC and its myriad research projects. Since the focus of our Center has been historically on late onset AD, most of our demented Autopsy donors and our normal controls are very elderly. Mixed dementias and overlapping neurodegenerative syndromes are common. The Core has successfully developed standardized protocols for tissue processing, analysis, and diagnosis. Additionally, modern diagnostic criteria are continually updated and consistently applied by the Core Leader. A major function of this Core is to support cutting-edge research both directly and indirectly by providing tissue and other biological samples from well-characterized AD patients and from age-matched normal control subjects for research projects. Currently 1,047 fixed and frozen human brain specimens are available of which 128 are normal controls. The Core provides research material for trainees and stimulates innovative research related to clinical-pathological correlations in normal aging and neurodegenerative diseases and contributes to numerous genetic and epidemiologic studies.
The Specific Aims of the Neuropathology Core are: 1. Provide diagnostic support for the Clinical Core, using standardized neuropathology assessment, by examining enrolled AD patients and genetic family members postmortem. 2. Expand and further develop brain banking functions for targeted populations: minority, normal controls, and subjects with Mild Cognitive Impairment (MCI). 3. Coordinate collection, storage and dissemination of high quality autopsy tissue, documented by quantitative RNA assessment, for research investigations. 4. Faciliate genomic medicine studies such as the envisioned gene expression studies with the IGSP and future studies to identify brain biomarkers related to transitions from MCI to dementia. 5. Continue our productive collaborations with the National Alzheimer's Coordinating Center (NACC) as well as with other program projects at Duke including the Udall Parkinson's Disease Research Center, the Center for Human Genetics, the National Academy of Sciences Twin Study, the Conte Center for the Neuroscience of Depression and the Cache County Utah Study of Memory in Aging.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Duke University
United States
Zip Code
Winawer, Melodie R; Griffin, Nicole G; Samanamud, Jorge et al. (2018) Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy. Ann Neurol 83:1133-1146
Epi4K Consortium; EuroEPINOMICS-RES Consortium; Epilepsy Phenome Genome Project (2017) Application of rare variant transmission disequilibrium tests to epileptic encephalopathy trio sequence data. Eur J Hum Genet 25:894-899
Sims, Rebecca (see original citation for additional authors) (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet 49:1373-1384
Gelfman, Sahar; Wang, Quanli; McSweeney, K Melodi et al. (2017) Annotating pathogenic non-coding variants in genic regions. Nat Commun 8:236
Mori, Mari; Haskell, Gloria; Kazi, Zoheb et al. (2017) Sensitivity of whole exome sequencing in detecting infantile- and late-onset Pompe disease. Mol Genet Metab 122:189-197
Jun, Gyungah R; Chung, Jaeyoon; Mez, Jesse et al. (2017) Transethnic genome-wide scan identifies novel Alzheimer's disease loci. Alzheimers Dement 13:727-738
Szabo, Steven T; Harry, G Jean; Hayden, Kathleen M et al. (2016) Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls. Toxicol Sci 150:292-300
Lutz, Michael W; Sundseth, Scott S; Burns, Daniel K et al. (2016) A Genetics-based Biomarker Risk Algorithm for Predicting Risk of Alzheimer's Disease. Alzheimers Dement (N Y) 2:30-44
Perry, David C; Sturm, Virginia E; Peterson, Matthew J et al. (2016) Association of traumatic brain injury with subsequent neurological and psychiatric disease: a meta-analysis. J Neurosurg 124:511-26
Jun, G; Ibrahim-Verbaas, C A; Vronskaya, M et al. (2016) A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry 21:108-17

Showing the most recent 10 out of 110 publications